Drug IndexRemicade (infliximab)
Billing
Code: J1745
Description: Infliximab not biosimil 10mg
Unit: 10 MG
Payment: $31.671
Pay quarter: Q2 2024
Covered in Part D: No
Drug Cost
Calculate drug cost and reimbursement
Total WAC:
$3,503.46Total Reimbursement:
$950.13(ASP: $896.35, Margin: $53.78)
.
.# Units to bill:
30Dosage & Frequency
Crohn's Disease (CD)
Ulcerative Colitis (UC)
Ankylosing Spondylitis (AS)
Psoriatic Arthritis (PsA)
Plaque Psoriasis (Ps)
Induction:
• 5mg/kg IV at 0, 2, and 6 weeks
Maintenance:
• 5mg/kg IV every 8 weeks
Ulcerative Colitis (UC)
Ankylosing Spondylitis (AS)
Psoriatic Arthritis (PsA)
Plaque Psoriasis (Ps)
Induction:
• 5mg/kg IV at 0, 2, and 6 weeks
Maintenance:
• 5mg/kg IV every 8 weeks
Rheumatoid Arthritis (RA)
Induction:
• 3mg/kg IV at 0, 2, and 6 weeks
Maintenance:
• 3mg/kg IV every 8 weeks
Induction:
• 3mg/kg IV at 0, 2, and 6 weeks
Maintenance:
• 3mg/kg IV every 8 weeks
Billable NDCs
57894-0030-01
Remicade (JANSSEN BIOTECH, INC.)
100 MG
57894-0160-01
INFLIXIMAB (JANSSEN BIOTECH, INC.)
100 MG
Prior Authorization
Resources